FDA
approval
· 2022-12-15
FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
Summary
The FDA approved a supplemental application for Norvir (ritonavir) submitted by AbbVie Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NORVIR (RITONAVIR)